In recent months a spate of mutations have been found in a disease protein called TDP-43 that is implicated in two neurodegenerative disorders: amyotrophic lateral sclerosis (ALS), also called Lou Gehrig’s disease, and certain types of frontotemporal dementia (FTD). These mutations could potentially become candidates for drug targets.

More: continued here

This entry was posted on Tuesday, April 8th, 2008 at 4:04 am and is filed under Muscular Dystrophy. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.